Shruti M. Raja

Classical Complement Pathway Inhibition in a “Human‐On‐A‐Chip” Model of Autoimmune Demyelinating Neuropathies

John W. Rumsey, Case Lorance, Max Jackson et al. · Advanced Therapeutics · 2022 · 71 citations · Full text

Chronic Inflammatory, Immunology, Immune Regulation +19

The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor–induced apoptosis

Shruti M. Raja, Shuzhen Chen, Ping Yue et al. · Molecular Cancer Therapeutics · 2008 · 47 citations · Full text

Chemoprevention Strategy, Apoptosis, Immunology +17

Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study

Pushpa Narayanaswami, Donald B. Sanders, Laine Thomas et al. · The Lancet Neurology · 2024 · 44 citations

Mycophenolate Mofetil, Clinical Epidemiology, Clinical Trials +5

Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Escalating Dose and Repeated Doses of CN-105 in Healthy Adult Subjects

Jeffrey T. Guptill, Shruti M. Raja, Felix Boakye‐Agyeman et al. · The Journal of Clinical Pharmacology · 2016 · 39 citations · Full text

Spontaneous Intracranial Hemorrhage, Single Escalating Dose, Pharmacotherapy +24

B10 Cell Frequencies and Suppressive Capacity in Myasthenia Gravis Are Associated with Disease Severity

John S. Yi, Melissa A. Russo, Janice M. Massey et al. · Frontiers in Neurology · 2017 · 29 citations · Full text